Search research articles
Contact Us
Filters
Showing results (191-200 of 201) with videos related to
Page
of 21
Sort By:
United European Gastroenterology Journal
|
October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective
Tommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
January 28, 2022
Management of eosinophilic esophagitis associated food impaction in Europe and the United States
Philipp Schreiner, Ekaterina Safroneeva, Alain Schoepfer, et al.
Inflammatory Intestinal Diseases
|
August 15, 2024
Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)
Jeanine Wakim El-Khoury, Ekaterina Safroneeva, Catherine Saner, et al.
The New England Journal of Medicine
|
June 30, 2021
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease
Detlef Schuppan, Markku Mäki, Knut E A Lundin, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 2, 2016
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment
Thomas Greuter, Fabio Bertoldo, Roman Rechner, et al.
Gut Microbes
|
July 21, 2025
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease
Yasser Morsy, Åsa Walberg, Paulina Wawrzyniak, et al.
JAMA
|
July 22, 2024
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials
Edouard Louis, Stefan Schreiber, Remo Panaccione, et al.
Gastrointestinal Endoscopy
|
February 5, 2022
Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis
Christopher Ma, Albert J Bredenoord, Evan S Dellon, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study
Uri Kopylov, Bram Verstockt, Luc Biedermann, et al.
Allergy
|
October 7, 2024
The epithelial barrier theory and its associated diseases
Na Sun, Ismail Ogulur, Yasutaka Mitamura, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 201) with videos related to
Sort By:
Page
of 21
United European Gastroenterology Journal
|
October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective
Tommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
January 28, 2022
Management of eosinophilic esophagitis associated food impaction in Europe and the United States
Philipp Schreiner, Ekaterina Safroneeva, Alain Schoepfer, et al.
Inflammatory Intestinal Diseases
|
August 15, 2024
Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)
Jeanine Wakim El-Khoury, Ekaterina Safroneeva, Catherine Saner, et al.
The New England Journal of Medicine
|
June 30, 2021
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease
Detlef Schuppan, Markku Mäki, Knut E A Lundin, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 2, 2016
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment
Thomas Greuter, Fabio Bertoldo, Roman Rechner, et al.
Gut Microbes
|
July 21, 2025
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease
Yasser Morsy, Åsa Walberg, Paulina Wawrzyniak, et al.
JAMA
|
July 22, 2024
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials
Edouard Louis, Stefan Schreiber, Remo Panaccione, et al.
Gastrointestinal Endoscopy
|
February 5, 2022
Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis
Christopher Ma, Albert J Bredenoord, Evan S Dellon, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study
Uri Kopylov, Bram Verstockt, Luc Biedermann, et al.
Allergy
|
October 7, 2024
The epithelial barrier theory and its associated diseases
Na Sun, Ismail Ogulur, Yasutaka Mitamura, et al.
Page
of 21